Mental Health / Psychiatry
Peer-reviewed studies and reviews on Deep TMS for Obsessive Compulsive Disorder (OCD).
Showing Obsessive Compulsive Disorder (OCD) · 19–36 of 41
Deep repetitive transcranial magnetic stimulation (DTMS), using the H7 coil, is an approved treatment for obsessive-compulsive disorder (OCD) by the United States Food and Drug Administration (US-FDA). The clinical efficacy and safety of accelerated regimens of DTMS have been previously studied extensively.…
Obsessive-compulsive disorder is one of the most common neuropsychiatric disorders with a higher lifetime prevalence than schizophrenia, often showing inadequate response to pharmacological and psychotherapeutic treatments. Objective: This study aimed to examine the efficacy of adjunctive deep transcranial magnetic stimulation (dTMS) in…
Obsessive-compulsive disorder (OCD) is a chronic debilitating mental illness with waxing and waning courses. The H7 coil used for deep repetitive transcranial magnetic stimulation (dTMS) is designed to produce deeper and broader neuronal stimulation in the dorsomedial prefrontal cortex and anterior cingulate…
Of late, the interest in accelerated treatment protocols in repetitive transcranial magnetic stimulation (TMS) for the treatment of depression and obsessive-compulsive disorder (OCD) has been gaining momentum. Studies have already found that the patterned theta burst stimulation is non-inferior to the standard…
In the last couple of decades, newer treatment modalities, including neuromodulation through brain stimulation and psychosurgery have been examined to treat SRI-resistant OCD. A systematic review of brain stimulation treatments for resistant OCD suggested the efficacy of low-frequency TMS over the supplementary…
Anxiety disorders, including occupational stress and generalized anxiety disorder (GAD), are prevalent mental health conditions with significant impacts on individuals' daily functioning and quality of life. Deep Transcranial Magnetic Stimulation (TMS) is a non-invasive brain stimulation technique that holds promise in alleviating…
Evidence suggests that depressive symptoms tend to improve concurrently with obsessive-compulsive disorder (OCD) symptoms during cognitive behavioral therapy (CBT), despite depression not being the primary target of intervention. Studies examining the temporal or mediational relationships of OCD and depressive symptoms have indicated…
Two patient cases illustrate the safety and potential clinical effectiveness of an accelerated deep transcranial magnetic stimulation (dTMS) protocol as an adjunctive approach in treating OCD. In contrast to the conventional once-daily protocol, the accelerated protocol may lead to quicker clinical improvement.…
We describe the first instance of dTMS application using H7 coil in an adolescent for childhood-onset OCD to evaluate the safety and efficacy of dTMS as an add-on treatment leading to the rapid and significant clinical improvement shown after 10 sessions in…
Obsessive-compulsive disorder (OCD) stands as one of the most prevalent neuropsychiatric disorders, surpassing the lifetime prevalence of schizophrenia and bipolar disorders. Many individuals with OCD do not adequately respond to currently available pharmacological and psychotherapeutic interventions. Consequently, there is growing interest in…
Existing evidence suggests a concurrent improvement in depressive symptoms alongside obsessive-compulsive disorder (OCD) symptoms during cognitive behavioral therapy (CBT), even though depression is not the primary focus of the intervention. Studies exploring the temporal and mediational links between OCD and depressive symptoms…
Treatment-resistant obsessive-compulsive disorder (OCD) is a chronic debilitating illness. Numerous interventions have been studied, to varying success, in published randomized controlled trials. Objective: Conduct a network meta-analysis (NMA) to compare the efficacy of all interventions in SRI-resistant OCD from published Randomised controlled…
Key Points: Converging lines of evidence suggest that OCD involves dysfunction of limbic cortico-striato-thalamo-cortico loops including the orbitofrontal cortex, medial prefrontal cortex (mPFC) and anterior cingulate cortex (ACC). The H7 Coil was FDA-cleared for treatment-refractory OCD based on results of two RCTs.…
OCD affects ~1.2% of individuals each year and confers significant impairment. Approximately 40–60% of adults respond to SRIs; CBT response rates range from 70 to 85%. However, partial- and non-response is common, resulting in a sizable number of treatment refractory individuals Deep TMS provides an additional…
The Deep TMS H7 Coil for treatment-resistant OCD has demonstrated 38% response rate that was sustained for at least a month in a multicenter randomized controlled trial. In real-world clinical practice settings 52.4% of patients achieved at least one month sustained response.…
In 2018, the FDA cleared deep transcranial magnetic stimulation (BrainsWay Deep TMS) with the H7 coil for obsessive-compulsive disorder (OCD) treatment following a double-blinded placebo-controlled multicenter trial. Magventure's D-B80 Coil was FDA-cleared in August 2020 to treat Obsessive-Compulsive Disorder (OCD), using the…
OCD patients frequently have additional psychiatric illness, the most common being MDD. In 2018 the FDA cleared Deep TMS H7 Coil for the treatment of refractory OCD, based on the efficacy results of a multicenter study. The H7 Coil and its stimulation…
Anxiety is a key aspect of many mental health disorders and a central theme in the world of mental health. Read on to learn more about this common concern.
